Camber Pharmaceuticals Launches Generic Methylin®
Piscataway, NJ, April 30, 2018– Camber Pharmaceuticals is pleased to announce the addition of Methylphenidate Chewable Tablet to our growing portfolio of products.
Methylphenidate Chewable tablet is the generic version of Methylin®. Methylphenidate is used to treat attention deficit hyperactivity disorder- ADHD.
Methylphenidate Chewable tablets are available in 2.5, 5 and 10mg 100ct bottles.
Camber’s commitment to its customers is to bring the highest quality generic pharmaceuticals to the market and provide a level of excellence in service, supply and affordability.
If you would like more information about this topic, please contact Kirk Hessels at 732.529.0430 or email at [email protected]
Recent articles
- Camber Launches 13 New Generic Products in Q1 2025, Sets Ambitious Pace for the Year
- Camber Launches Mycophenolate Mofetil Capsules
- Camber Launches Sodium Sulfate, Potassium Sulfate and Magnesium Sulfate Oral Solution
- Camber’s Triple Play – Featured Generics
- Big Game Commercial
- Charting a Bold Path for 2025